Achieving tolerance modifies cancer susceptibility profiles in liver transplant recipients

Long‐term survival of transplant recipients is significantly impacted by malignancy. We aimed to determine whether calcineurin inhibitor (CNI)‐treated recipients converted to and weaned off molecular target of rapamycin inhibitor (mTOR‐I) therapy have favorable changes in their molecular profiles in...

Descripción completa

Detalles Bibliográficos
Autores principales: Bhat, Mamatha, Pasini, Elisa, Patel, Preya, Yu, Jeffrey, Baciu, Cristina, Kurian, Sunil M., Levitsky, Josh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972022/
https://www.ncbi.nlm.nih.gov/pubmed/36205189
http://dx.doi.org/10.1002/cam4.5271

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9972022/
https://www.ncbi.nlm.nih.gov/pubmed/36205189
http://dx.doi.org/10.1002/cam4.5271

Ejemplares similares